Colorado Child Fatality Prevention System Overview Presentation
Presented to the Joint Health Committees on January 9, 2017.
First Regular Session | 75th General Assembly
Colorado General AssemblyPresented to the Joint Health Committees on January 9, 2017.
Presented to the Joint Health Committees.
Presented to the Joint Health Committee.
Presented to the Joint Health Committee.
Presented to the Joint Health Committee on January 6, 2017.
Presented to the Joint Health Committee on January 6, 2017.
Presented to the Joint Health Committee.
Colorado receives annual payments from tobacco manufacturers as part of the Tobacco Master Settlement Agreement. In April 2016, the state received $92.3 million. This memorandum presents the distribution of the 2016 payment and forecasts payments through 2019.
This issue brief provides an overview of how the justice system treats juveniles found guilty of a crime in Colorado. It discusses juvenile problem solving courts; detention and commitment; the facilities where juveniles are housed; the programs and services available; requirements for...
The Legislative Council Staff's Health Care Resource Book is intended to serve as a reference guide for information on some of Colorado's major health care issues and programs. The book is divided into two sections.
The first section covers health care spending; private health insurance...
This memorandum provides an overview of the 2017 membership of the Opioid and Other Substance Use Disorders Interim Study Committee, the origin and charge of the committee, bill request deadlines and procedures, and information regarding committee staff and the committee website. Information is...
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.